Structures by: Kong Y. J.
Total: 13
C10H12F2N2O5
C10H12F2N2O5
Journal of medicinal chemistry (2019) 62, 13 6346-6362
a=5.8735(2)Å b=13.5166(5)Å c=14.1374(5)Å
α=90° β=90° γ=90°
C11H13F2N5O3,1.5(H2O)
C11H13F2N5O3,1.5(H2O)
Journal of medicinal chemistry (2019) 62, 13 6346-6362
a=10.20373(8)Å b=6.97368(6)Å c=18.69692(15)Å
α=90° β=96.8278(7)° γ=90°
C10H13FN2O5
C10H13FN2O5
Journal of medicinal chemistry (2019) 62, 13 6346-6362
a=6.6465(2)Å b=6.6465(2)Å c=43.3632(14)Å
α=90° β=90° γ=120°
C24H89N16Ni4O50PV18
C24H89N16Ni4O50PV18
RSC Adv. (2016)
a=11.7978(9)Å b=26.8599(19)Å c=23.7929(17)Å
α=90.00° β=90.00° γ=90.00°
C48H16Cu2F20N4O8
C48H16Cu2F20N4O8
Dalton transactions (Cambridge, England : 2003) (2016) 45, 46 18566-18571
a=9.6512(14)Å b=9.9482(14)Å c=12.8890(18)Å
α=102.876(2)° β=99.000(2)° γ=96.733(2)°
C48H16Cu2F20N4O8
C48H16Cu2F20N4O8
Dalton transactions (Cambridge, England : 2003) (2016) 45, 46 18566-18571
a=9.6531(19)Å b=9.952(2)Å c=12.890(3)Å
α=102.83(3)° β=99.04(3)° γ=96.71(3)°
C24H20CuN2O5
C24H20CuN2O5
Dalton transactions (Cambridge, England : 2003) (2016) 45, 46 18566-18571
a=6.9830(7)Å b=18.8482(17)Å c=17.0174(16)Å
α=90° β=97.9690(10)° γ=90°
<i>catena</i>-Poly[[aqua(2,2-bipyridine-κ^2^<i>N</i>,<i>N</i>')(2,3,4,5,6-pentafluorobenzoato-κ<i>O</i>)cadmium(II)]-μ-2,3,4,5,6-pentafluorobenzoato-κ^2^<i>O</i>:<i>O</i>']
C24H10CdF10N2O5
Acta Crystallographica Section C (2017) 73, 5 424-429
a=12.9134(17)Å b=21.035(3)Å c=9.1946(12)Å
α=90° β=93.696(2)° γ=90°
<i>catena</i>-Poly[[diaquabis(2,3,4,5,6-pentafluorobenzoato-κ<i>O</i>)cadmium(II)]-μ-4,4-bipyridine-κ^2^<i>N</i>:<i>N</i>]
C24H12CdF10N2O6
Acta Crystallographica Section C (2017) 73, 5 424-429
a=21.402(5)Å b=11.711(2)Å c=10.955(2)Å
α=90° β=106.639(3)° γ=90°
Poly[[(μ-pentafluorobenzoato-κ^2^<i>O</i>:<i>O</i>)(pentafluorobenzoato-κ<i>O</i>)(μ-pyrazine-κ^2^<i>N</i>:<i>N</i>'</i>)copper(II)]:
C18H4CuF10N2O4
Acta Crystallographica Section C (2014) 70, 11 1017-1020
a=4.8046(9)Å b=13.072(2)Å c=15.357(3)Å
α=89.785(2)° β=89.660(2)° γ=86.666(2)°
Poly[[(μ-pentafluorobenzoato-κ^2^<i>O</i>:<i>O</i>)(pentafluorobenzoato-κ<i>O</i>)(μ-pyrazine-κ^2^<i>N</i>:<i>N</i>'</i>)copper(II)]:
C18H4CuF10N2O4
Acta Crystallographica Section C (2014) 70, 11 1017-1020
a=4.8100(12)Å b=13.095(3)Å c=15.366(4)Å
α=89.784(3)° β=89.654(3)° γ=86.678(3)°
(2-Hydroxyacetato-κ<i>O</i>^1^)bis(1,10-phenanthroline- κ^2^<i>N</i>,<i>N</i>)copper(II) nitrate
C26H19CuN4O3,NO3
Acta Crystallographica Section E (2011) 67, 5 m592
a=21.718(4)Å b=14.347(3)Å c=16.311(3)Å
α=90.00° β=117.045(3)° γ=90.00°
C36H122N24Ni4O46PV18
C36H122N24Ni4O46PV18
RSC Adv. (2016)
a=17.5402(10)Å b=17.5402(10)Å c=17.5402(10)Å
α=90.00° β=90.00° γ=90.00°